SCF inhibitors, short for Stem Cell Factor inhibitors, belong to a specific chemical class known for their ability to modulate the activity of stem cell factor (SCF), a crucial cytokine involved in various physiological processes. SCF, also called c-kit ligand, plays a fundamental role in the regulation of hematopoiesis, cell survival, proliferation, and differentiation, particularly in the context of hematopoietic stem cells. The chemical compounds falling under the category of SCF inhibitors have been extensively studied for their interactions with SCF and their impact on cellular processes.
These inhibitors typically function by binding to specific receptors or signaling pathways associated with SCF, thereby affecting downstream cellular responses. By interfering with SCF signaling, they can influence the fate and behavior of stem cells and other cell types in the body. Researchers have developed various types of SCF inhibitors, ranging from small molecules to antibodies, with the aim of gaining a deeper understanding of SCF-mediated processes and modulating them for various applications. These compounds have been instrumental in elucidating the intricate molecular mechanisms governing stem cell regulation and have opened up avenues for exploring their broader implications in basic science and beyond.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Imatinib | 152459-95-5 | sc-267106 sc-267106A sc-267106B | 10 mg 100 mg 1 g | $26.00 $119.00 $213.00 | 27 | |
Inhibits c-Kit kinase activity, preventing SCF signaling. | ||||||
Crenolanib | 670220-88-9 | sc-364470 sc-364470A | 5 mg 10 mg | $612.00 $1020.00 | ||
Targets and inhibits c-Kit, the receptor for SCF. | ||||||
Masitinib | 790299-79-5 | sc-211777 | 10 mg | $184.00 | ||
Inhibits c-Kit and PDGFR, disrupting SCF-mediated signaling. | ||||||
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $57.00 $100.00 $250.00 | 129 | |
Targets multiple kinases, including c-Kit involved in SCF signaling. | ||||||
Sunitinib, Free Base | 557795-19-4 | sc-396319 sc-396319A | 500 mg 5 g | $153.00 $938.00 | 5 | |
Inhibits c-Kit, PDGFR, and VEGFR, blocking SCF signaling. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
Suppresses c-Kit and other kinases downstream of SCF. | ||||||
PKC-412 | 120685-11-2 | sc-200691 sc-200691A | 1 mg 5 mg | $52.00 $114.00 | 10 | |
Inhibits c-Kit and FLT3, disrupting SCF-driven pathways. | ||||||
Regorafenib | 755037-03-7 | sc-477163 sc-477163A | 25 mg 50 mg | $320.00 $430.00 | 3 | |
Blocks several kinases, including c-Kit in SCF pathways. | ||||||
Quizartinib, Free Base | 950769-58-1 | sc-396767 sc-396767A | 1 mg 5 mg | $68.00 $150.00 | ||
Selective FLT3 inhibitor, indirectly impacting SCF signaling. | ||||||
ABT-869 | 796967-16-3 | sc-359037 sc-359037A | 1 mg 5 mg | $126.00 $582.00 | ||
Targets VEGFR and PDGFR, indirectly affecting SCF pathways. | ||||||